CA3298574A1 - Compositions et méthodes thérapeutiques de changement de l'acidité du sang - Google Patents

Compositions et méthodes thérapeutiques de changement de l'acidité du sang

Info

Publication number
CA3298574A1
CA3298574A1 CA3298574A CA3298574A CA3298574A1 CA 3298574 A1 CA3298574 A1 CA 3298574A1 CA 3298574 A CA3298574 A CA 3298574A CA 3298574 A CA3298574 A CA 3298574A CA 3298574 A1 CA3298574 A1 CA 3298574A1
Authority
CA
Canada
Prior art keywords
acid
methods
therapeutic blood
shifting
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3298574A
Other languages
English (en)
Inventor
James D. Ervin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA3298574A1 publication Critical patent/CA3298574A1/fr
Pending legal-status Critical Current

Links

CA3298574A 2023-07-13 2024-07-12 Compositions et méthodes thérapeutiques de changement de l'acidité du sang Pending CA3298574A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63/526,524 2023-07-13
US18/771,555 2024-07-12

Publications (1)

Publication Number Publication Date
CA3298574A1 true CA3298574A1 (fr) 2025-01-16

Family

ID=

Similar Documents

Publication Publication Date Title
AU2022342169A1 (en) Hbb-modulating compositions and methods
EP4090752A4 (fr) Procédés et compositions de thérapie génique basée sur la plakophiline 2
AU2022342168A1 (en) Pah-modulating compositions and methods
CA3261160A1 (fr) Composés et méthodes thérapeutiques
CA3260587A1 (fr) Compositions et méthodes de modulation de fah
CA3263582A1 (fr) Compositions et méthodes pour induire la ferroptose
CA3262115A1 (fr) Compositions de mucispirillum et méthodes de traitement du cancer associées
HK40116068A (en) Novel compositions and therapeutic methods
AU2023901412A0 (en) Therapeutic Agents and Compositions and Related Methods
CA3280255A1 (fr) Méthodes et compositions pour polythérapie
CA3280256A1 (fr) Méthodes et compositions pour polythérapie
AU2026900846A0 (en) Therapeutic compositions and related methods
AU2025901184A0 (en) Therapeutic compositions and related methods
AU2026901963A0 (en) Therapeutic methods and compositions and uses thereof
AU2024900070A0 (en) Therapeutic methods and related compositions
CA3299185A1 (fr) Compositions et méthodes de piège à lair-2 et tnt
CA3285068A1 (fr) Compositions et procédés de modulation de serpina
AU2024215379A1 (en) Compositions and methods
CA3275752A1 (fr) Compositions et procédés
GB202300911D0 (en) Therapeutic compositions and methods
GB202219334D0 (en) therapeutic compositions and methods
AU2023901845A0 (en) Methods and compositions
HK40120805A (en) Anti-ilt4 compositions and methods
AU2023900291A0 (en) Methods and compositions
AU2023902710A0 (en) Pharmaceutical compositions and methods